Mutations of the PU.1 Ets domain are specifically associated with murine radiation-induced, but not human therapy-related, acute myeloid leukaemia
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Murine radiation-induced acute myeloid leukaemia (AML) is characterized by loss of one copy of chromosome 2. Previously, we positioned the critical haematopoietic-specific transcription factor PU.1 within a minimally deleted region. We now report a high frequency (>65%) of missense mutation at codon 235 in the DNA-binding Ets domain of PU.1 in murine AML. Earlier studies, outside the context of malignancy, determined that conversion of arginine 235 (R235) to any other amino-acid residue leads to ablation of DNA-binding function and loss of expression of downstream targets. We show that mutation of R235 does not lead to protein loss, and occurs specifically in those AMLs showing loss of one copy of PU.1 (P=0.001, Fisher's exact test). PU.1 mutations were not found in the coding region, UTRs or promoter of human therapy-related AMLs. Potentially regulatory elements upstream of PU.1 were located but no mutations found. In conclusion, we have identified the cause of murine radiation-induced AML and have shown that loss of one copy of PU.1, as a consequence of flanking radiation-sensitive fragile domains on chromosome 2, and subsequent R235 conversion are highly specific to this mouse model. Such a mechanism does not operate, or is extremely rare, in human AML.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Likewise, irradiationinduced myeloid leukemias in mice had low PU.1 levels and mutations that affected its binding to the DNA.41,42”
From USP22 deficiency leads to myeloid leukemia upon oncogenic Kras activation through a PU.1-dependent mechanism (2018) · cites this paper as [42]
Citations
Cites
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00949.x · Cited by 1,130
The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene
Klemsz, M. J., McKercher, S. R., Celada, A., Van Beveren, C., & Maki, R. A. (1990) · Cell · doi:10.1016/0092-8674(90)90219-5 · Cited by 954
Transcription Factors, Normal Myeloid Development, and Leukemia
Tenen, D. G., Hromas, R., Licht, J. D., & Zhang, D.-E. (1997) · Blood · doi:10.1182/blood.v90.2.489 · Cited by 735 · cited 1×
“…therapy related; Ets domain; mutation PU.1 is a member of the ETS family of transcription factors and is essential for the development of both myeloid (macrophages and neutrophils) and lymphoid lineages (B- and T-lymphocytes) (Moreau-Gachelin et al., 1989; Klemsz et al., 1990; Tenen et al., 1997).”
BackgroundA breakpoint map of recurrent chromosomal rearrangements in human neoplasia
Mitelman, F., Mertens, F., & Johansson, B. (1997) · Nature Genetics · doi:10.1038/ng0497supp-417 · Cited by 698
Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1.
Rosenbauer, F., Wagner, K., Kutok, J. L., Iwasaki, H., Le Beau, M. M., Okuno, Y., Akashi, K., Fiering, S., & Tenen, D. G. (2004) · Nature Genetics · doi:10.1038/ng1361 · Cited by 506
Zhang, D.-E., Hetherington, C. J., Chen, H.-M., & Tenen, D. G. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.373-381.1994 · Cited by 411
Long-range disruption of gene expression by a selectable marker cassette
Pham, C. T. N., MacIvor, D. M., Hug, B. A., Heusel, J. W., & Ley, T. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13090 · Cited by 365
Smith, L., Hohaus, S., Gonzalez, D., Dziennis, S., & Tenen, D. (1996) · Blood · doi:10.1182/blood.v88.4.1234.bloodjournal8841234 · Cited by 332
A new pattern for helix–turn–helix recognition revealed by the PU.l ETS–domain–DNA complex
Kodandapani, R., Pio, F., Ni, C.-Z., Piccialli, G., Klemsz, M., McKercher, S., Maki, R. A., & Ely, K. R. (1996) · Nature · doi:10.1038/380456a0 · Cited by 315 · cited 3×
“…factors is characterized by a highly conserved region of amino acids that form a winged (aþ b) helix-turn-helix motif, which binds DNA to facilitate promoter-specific transcriptional responses (Donaldson et al., 1994; Kodandapani et al., 1996; Pio et al., 1996; Jia et al., 1999; Figure 3).”
Background
Cited by
Transcription factors in myeloid development: balancing differentiation with transformation
Rosenbauer, F., & Tenen, D. G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2024 · Cited by 606
PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis.
Huang, G., Zhang, P., Hirai, H., Elf, S., Yan, X., Chen, Z., Koschmieder, S., Okuno, Y., Dayaram, T., Growney, J. D., et al. (2008) · Nature Genetics · doi:10.1038/ng.2007.7 · Cited by 259
Assessing cancer risks of low-dose radiation
Mullenders, L., Atkinson, M., Paretzke, H., Sabatier, L., & Bouffler, S. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2677 · Cited by 213
Mueller, B. U., Pabst, T., Fos, J., Petkovic, V., Fey, M. F., Asou, N., Buergi, U., & Tenen, D. G. (2006) · Blood · doi:10.1182/blood-2005-07-3068 · Cited by 207
Transcriptional dysregulation during myeloid transformation in AML
Pabst, T., & Mueller, B. U. (2007) · Oncogene · doi:10.1038/sj.onc.1210765 · Cited by 120
Steidl, U., Steidl, C., Ebralidze, A., Chapuy, B., Han, H.-J., Will, B., Rosenbauer, F., Becker, A., Wagner, K., Koschmieder, S., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30525 · Cited by 114
Effect of transcription-factor concentrations on leukemic stem cells
Rosenbauer, F., Koschmieder, S., Steidl, U., & Tenen, D. G. (2005) · Blood · doi:10.1182/blood-2005-02-0717 · Cited by 98
Melo-Cardenas, J., Xu, Y., Wei, J., Tan, C., Kong, S., Gao, B., Montauti, E., Kirsammer, G., Licht, J. D., Yu, J., et al. (2018) · Blood · doi:10.1182/blood-2017-10-811760 · Cited by 84
Walter, M. J., Park, J. S., Ries, R. E., Lau, S. K. M., McLellan, M., Jaeger, S., Wilson, R. K., Mardis, E. R., & Ley, T. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504247102 · Cited by 83
PU.1 and Haematopoietic Cell Fate: Dosage Matters
Mak, K. S., Funnell, A. P. W., Pearson, R. C. M., & Crossley, M. (2011) · International Journal of Cell Biology · doi:10.1155/2011/808524 · Cited by 77
“1 mutations and AML [45–47], suggesting that the mutations identified in the Mueller study may be linked to rare subsets of the disease.”
BackgroundIs PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis?
Dakic, A., Wu, L., & Nutt, S. L. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.01.006 · Cited by 72
Peng, Y., Brown, N., Finnon, R., Warner, C. L., Liu, X., Genik, P. C., Callan, M. A., Ray, F. A., Borak, T. B., Badie, C., et al. (2009) · Radiation Research · doi:10.1667/rr1547.1 · Cited by 62
Bednarski, J. J., Pandey, R., Schulte, E., White, L. S., Chen, B.-R., Sandoval, G. J., Kohyama, M., Haldar, M., Nickless, A., Trott, A., et al. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20151048 · Cited by 52
Kosmider, O., Denis, N., Lacout, C., Vainchenker, W., Dubreuil, P., & Moreau-Gachelin, F. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.11.009 · Cited by 49
Bruserud, Ø., Stapnes, C., Tronstad, K. J., Ryningen, A., Ånensen, N., & Gjertsen, B. T. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.1.51 · Cited by 49
PU.1 is regulated by NF-κB through a novel binding site in a 17 kb upstream enhancer element
Bonadies, N., Neururer, C., Steege, A., Vallabhapurapu, S., Pabst, T., & Mueller, B. U. (2009) · Oncogene · doi:10.1038/onc.2009.371 · Cited by 47
Verbiest, T., Bouffler, S., Nutt, S. L., & Badie, C. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv016 · Cited by 46
Mouse models for radiation-induced cancers
Rivina, L., Davoren, M. J., & Schiestl, R. H. (2016) · Mutagenesis · doi:10.1093/mutage/gew019 · Cited by 46
Spi-1/PU.1 Oncoprotein Affects Splicing Decisions in a Promoter Binding-dependent Manner
Guillouf, C., Gallais, I., & Moreau-Gachelin, F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512049200 · Cited by 30
FIFTH WARREN K. SINCLAIR KEYNOTE ADDRESS: ISSUES IN QUANTIFYING THE EFFECTS OF LOW-LEVEL RADIATION
GOODHEAD, D. T. (2009) · Health Physics · doi:10.1097/hp.0b013e3181ae8acf · Cited by 41
Darakhshan, F., Badie, C., Moody, J. C., Coster, M., Finnon, R., Finnon, P., Edwards, A. A., Szłuińska, M., SKIDMORE, C. J., Yoshida, K., et al. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi207 · Cited by 39
Self-citationRimmelé, P., Kosmider, O., Mayeux, P., Moreau-Gachelin, F., & Guillouf, C. (2007) · Blood · doi:10.1182/blood-2006-03-006718 · Cited by 35
Radiation-induced myeloid leukemia in murine models
Rivina, L., Davoren, M. J., & Schiestl, R. H. (2014) · Human Genomics · doi:10.1186/1479-7364-8-13 · Cited by 35
Implication of replicative stress-related stem cell ageing in radiation-induced murine leukaemia
Ban, N., & Kai, M. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605135 · Cited by 35
Heterozygous deletion of the PU.1 locus in human AML
Bonadies, N., Pabst, T., & Mueller, B. U. (2010) · Blood · doi:10.1182/blood-2009-03-212225 · Cited by 33
Low-dose radiation accelerates aging of the T-cell receptor repertoire in CBA/Ca mice
Candéias, S. M., Mika, J., Finnon, P., Verbiest, T., Finnon, R., Brown, N., Bouffler, S. D., Polańska, J., & Badie, C. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2581-2 · Cited by 32
Flt3-ITD mutations in a mouse model of radiation-induced acute myeloid leukaemia
Finnon, R., Brown, N., Moody, J. C., Badie, C., Olme, C.-H., Huiskamp, R., Meijne, E. I. M., Sutmuller, M., Rosemann, M., & Bouffler, S. D. (2012) · Leukemia · doi:10.1038/leu.2011.377 · Cited by 32
Self-citationLentiviral PU.1 overexpression restores differentiation in myeloid leukemic blasts
Durual, S., Rideau, A., Ruault-Jungblut, S., Cossali, D., Beris, P., Piguet, V, & Matthes, T. (2007) · Leukemia · doi:10.1038/sj.leu.2404645 · Cited by 30
Hirouchi, T., Takabatake, T., Yoshida, K., Nitta, Y., Nakamura, M. M., Tanaka, S., Ichinohe, K., Oghiso, Y., & Tanaka, K. J. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2008.01.015 · Cited by 30
Self-citationNoguera, N. I., Piredda, M. L., Taulli, R., Catalano, G., Angelini, G., Gaur, G., Nervi, C., Voso, M. T., Lunardi, A., Pandolfi, P. P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11964 · Cited by 27
Brown, N., Finnon, R., Manning, G., Bouffler, S. D., & Badie, C. (2015) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2015.07.012 · Cited by 26
A two-mutation model of radiation-induced acute myeloid leukemia using historical mouse data
Dekkers, F., Bijwaard, H., Bouffler, S. D., Ellender, M., Huiskamp, R., Kowalczuk, C. I., Meijne, E. I. M., & Sutmuller, M. (2010) · Radiation and Environmental Biophysics · doi:10.1007/s00411-010-0328-7 · Cited by 23
Self-citationSive, J. I., Basilico, S., Hannah, R., Kinston, S. J., Calero-Nieto, F. J., & Göttgens, B. (2016) · Leukemia · doi:10.1038/leu.2015.172 · Cited by 17
Pharmacogenetics of Alkylator-Associated Acute Myeloid Leukemia
Knoche, E., McLeod, H. L., & Graubert, T. A. (2006) · Pharmacogenomics · doi:10.2217/14622416.7.5.719 · Cited by 19
Kras mutations and PU.1 promoter methylation are new pathways in murine radiation-induced AML
O’Brien, G., Cruz-Garcia, L., Żyła, J., Brown, N., Finnon, R., Polańska, J., & Badie, C. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz175 · Cited by 19
Mouse Models of Radiation-Induced Cancers
Rivina, L., & Schiestl, R. H. (2013) · Advances in genetics · doi:10.1016/b978-0-12-407703-4.00003-7 · Cited by 18
Olme, C.-H., Finnon, R., Brown, N., Kabacik, S., Bouffler, S. D., & Badie, C. (2013) · Leukemia Research · doi:10.1016/j.leukres.2013.05.019 · Cited by 18
Steffen, L. S., Bacher, J., Peng, Y., Le, P. N., Ding, L.-H., Genik, P. C., Ray, F. A., Bedford, J. S., Fallgren, C. M., Bailey, S. M., et al. (2012) · Mutagenesis · doi:10.1093/mutage/ges055 · Cited by 18
Moreau-Gachelin, F. (2006) · PubMed · Cited by 18
Olme, C.-H., Brown, N., Finnon, R., Bouffler, S. D., & Badie, C. (2013) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2013.04.018 · Cited by 17
Sasaki, M. S., Nomura, T., Ejima, Y., Utsumi, H., Endo, S., Saito, I., Itoh, T., & Hoshi, M. (2008) · Radiation Research · doi:10.1667/rr1249.1 · Cited by 17
Mouse Models for Efficacy Testing of Agents against Radiation Carcinogenesis — A Literature Review
Rivina, L., & Schiestl, R. H. (2012) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph10010107 · Cited by 16
Modeling low-dose radiation-induced acute myeloid leukemia in male CBA/H mice
Stouten, S., Lunel, S. M. V., Finnon, R., Badie, C., & Dekkers, F. (2020) · Radiation and Environmental Biophysics · doi:10.1007/s00411-020-00880-9 · Cited by 15
Brown, N., Finnon, R., Bulman, R. A., Finnon, P., Moody, J. C., Bouffler, S. D., & Badie, C. (2010) · Leukemia Research · doi:10.1016/j.leukres.2010.06.015 · Cited by 15
Self-citationYamada, T., Shimizu, T., Suzuki, M., Kihara‐Negishi, F., Nanashima, N., Sakurai, T., Yang, F., Akita, M., Oikawa, T., & Tsuchida, S. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.11.005 · Cited by 12
Jawad, M., Cole, C., Zanker, A., Lo, P., Fitch, S. R., & Plumb, M. (2006) · International Journal of Radiation Biology · doi:10.1080/09553000600784161 · Cited by 12
Transcriptomic and proteomic analysis of mouse radiation-induced acute myeloid leukaemia (AML)
Badie, C., Blachowicz, A., Barjaktarović, Ž., Finnon, R., Michaux, A., Sarioglu, H., Brown, N., Manning, G., Benotmane, M. A., Tapio, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9626 · Cited by 11
Radiation leukemogenesis: A proteomic approach
Rithidech, K. N., Honikel, L., & Simon, S. R. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2007.01.019 · Cited by 10
Oxidative Stress and X-ray Exposure Levels-Dependent Survival and Metabolic Changes in Murine HSPCs
Karabulutoglu, M., Finnon, R., Cruz-Garcia, L., Hill, M. A., & Badie, C. (2021) · Antioxidants · doi:10.3390/antiox11010011 · Cited by 9
Walter, M. J., Ries, R. E., Armstrong, J. R., Park, J. S., Mardis, E. R., & Ley, T. J. (2006) · Blood · doi:10.1182/blood-2006-07-037465 · Cited by 8
Zhou, J., Zhang, X., Wang, Y., & Guan, Y. (2015) · Oncology Letters · doi:10.3892/ol.2015.3404 · Cited by 7
Leukemogenesis in HeterozygousPU.1Knockout Mice
Genik, P. C., Vyazunova, I., Steffen, L. S., Bacher, J. W., Bielefeldt‐Ohmann, H., McKercher, S. R., Ullrich, R. L., Fallgren, C. M., Weil, M. M., & Ray, F. A. (2014) · Radiation Research · doi:10.1667/rr13738.1 · Cited by 7
Brown, N., Finnon, R., Finnon, P., McCarron, R., Cruz-Garcia, L., O’Brien, G., Herbert, E., Scudamore, C. L., Morel, E., & Badie, C. (2023) · iScience · doi:10.1016/j.isci.2023.107530 · Cited by 5
Hyper-radiosensitivity affects low-dose acute myeloid leukemia incidence in a mathematical model
Stouten, S., Balkenende, B., Roobol, L. P., Lunel, S. M. V., Badie, C., & Dekkers, F. (2022) · Radiation and Environmental Biophysics · doi:10.1007/s00411-022-00981-7 · Cited by 3
PU.1, a Versatile Transcription Factor and a Suppressor of Myeloid Leukemia
Takahashi, S. (2011) · InTech eBooks · doi:10.5772/25853 · Cited by 3
Animal mouse models of acute myeloid leukemia
Patel, T., Madhunapantula, S. V., Annageldiyev, C., Claxton, D. F., & Sharma, A. K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814704-7.00018-0 · Cited by 3
Ishikawa, J., & Morisaki, T. (2019) · International Journal of Medical Physics Clinical Engineering and Radiation Oncology · doi:10.4236/ijmpcero.2019.82009 · Cited by 1
Genomics of inherited bone marrow failure and myelodysplasia
Zhang, M. Y. (2015) · ResearchWorks at the University of Washington (University of Washington) · Cited by 1
Discovery and Characterization of Radiation Mitigator Yel002
Rivina, Y. (2013) · eScholarship (California Digital Library)
Cook, W. D. (2006) · Blood · doi:10.1182/blood-2006-01-0419
Verbiest, T. (2016) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-zg75ozpqw
Genetic and epigenetic consequences of radiation exposure in human and mouse leukaemogenesis
O’Brien, G. (2020) · Brunel University Research Archive (BURA) (Brunel University London)
Gregoricchio, S. (2021) · theses.fr (ABES) · doi:10.70675/f1d71abdzfa19z4e95z89e6zdfa431de5448
Karabulutoglu, M. (2023) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-6qbexxmqb
Ramani, M., Nguyen, N., Solis, J., Tenen, D. G., & Trinh, B. Q. (2026) · Biology · doi:10.3390/biology15181657
Metadata
- Authors
- Suraweera, N., Meijne, E., Moody, J., Carvajal-Carmona, L. G., Yoshida, K., Pollard, P., Fitzgibbon, J., Riches, A., van Laar, T., Huiskamp, R., Rowan, A., Tomlinson, I. P. M., & Silver, A.
- Affiliations
- Cancer Research UK (GB)
- Nuclear Research and Consultancy Group (NL)
- National Radiological Protection Board (GB)
- National Institute of Radiological Sciences (JP)
- St Bartholomew's Hospital (GB)
- University of St Andrews (GB)
- Corresponding author
- Silver, Andrew
- Venue
- Oncogene
- Published
- 2005-03-07
- Volume
- 24
- Issue
- 22
- Pages
- 3678-3683
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2062397105
- Semantic Scholar
- 5611af7e7954a33d42de06e06b159e33a8647600
- Cited by
- 60
- References
- 37
- Citations by year
- 2026: 1 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 3 · 2018: 1 · 2017: 1 · 2016: 4 · 2015: 5 · 2014: 2 · 2013: 3 · 2012: 3
- FWCI
- 4.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Cancer Research UK
- Fourth Framework Programme
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
- Keywords
- PU.1, ETS domain, acute myeloid leukemia, radiation-induced leukemia, therapy-related myeloid neoplasms, fragile sites, missense mutations, transcription factors, mouse model
- MeSH terms
- Proto-Oncogene Protein Spi-1, Animals, Base Sequence, Disease Models, Animal, Humans, Molecular Sequence Data, Mutation, Neoplasms, Radiation-Induced, Promoter Regions, Genetic, Proto-Oncogene Proteins, Transcription Factors, Blotting, Western, Leukemia, Myeloid, Acute, Trans-Activators, DNA Footprinting, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.